Invion (Australia) Today
| IVX Stock | 0.26 0.02 7.14% |
Performance6 of 100
| Odds Of DistressOver 80
|
Invion is selling for under 0.26 as of the 22nd of December 2024; that is 7.14 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.26. Invion has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Invion has reported 100 for 1 split on 20th of November 2024. The performance scores are derived for the period starting the 22nd of November 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Invion is entity of Australia. It is traded as Stock on AU exchange. The company has 69.27 M outstanding shares. More on Invion
Moving against Invion Stock
Invion Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Invion's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Invion or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive CEO | Thian Chew | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Invion's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Invion's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsInvion can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Invion's financial leverage. It provides some insight into what part of Invion's total assets is financed by creditors.
| |||||
Invion (IVX) is traded on Australian Securities Exchange in Australia and employs 4 people. Invion is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Invion's market, we take the total number of its shares issued and multiply it by Invion's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Invion operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 69.27 M outstanding shares.
Invion generates negative cash flow from operations
Check Invion Probability Of Bankruptcy
Ownership AllocationInvion has a total of 69.27 Million outstanding shares. Invion secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Invion Ownership Details
Invion Risk Profiles
Although Invion's alpha and beta are two of the key measurements used to evaluate Invion's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 13.18 | |||
| Semi Deviation | 13.44 | |||
| Standard Deviation | 22.31 | |||
| Variance | 497.85 |
Invion Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Invion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Additional Tools for Invion Stock Analysis
When running Invion's price analysis, check to measure Invion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invion is operating at the current time. Most of Invion's value examination focuses on studying past and present price action to predict the probability of Invion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invion's price. Additionally, you may evaluate how the addition of Invion to your portfolios can decrease your overall portfolio volatility.